Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 18, 2008
Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortalityMarc Brisson
Pharmacoeconomics|April 21, 2011
Modelling the epidemiology of infectious diseases for decision analysis: a primerMark Jit, Marc Brisson
International Journal of Cancer|February 16, 2018
Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14-year-old girls against human papillomavirusMark Jit, Marc Brisson
The Lancet. Oncology|February 24, 2019
Global elimination of cervical cancer as a public health problemMarc Brisson, Mélanie Drolet
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccination - Authors' replyMélanie Drolet, Marc Brisson
Journal of the National Cancer Institute|January 9, 2013
Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccinationMarc Brisson, Mélanie Drolet, Talía Malagón
Emerging Infectious Diseases|December 23, 2015
Human Papillomavirus Vaccination at a Time of Changing Sexual BehaviorIacopo Baussano, Fulvio Lazzarato, Marc Brisson, et al.
The Lancet. Global Health|August 9, 2014
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling studyMark Jit, Marc Brisson, Allison Portnoy, et al.
Preventive Medicine|December 14, 2020
From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectivenessMark Jit, Kiesha Prem, Elodie Benard, et al.
Lancet (London, England)|July 1, 2019
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysisMélanie Drolet, Élodie Bénard, Norma Pérez, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 18, 2008
Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortalityMarc Brisson
Pharmacoeconomics|April 21, 2011
Modelling the epidemiology of infectious diseases for decision analysis: a primerMark Jit, Marc Brisson
International Journal of Cancer|February 16, 2018
Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14-year-old girls against human papillomavirusMark Jit, Marc Brisson
The Lancet. Oncology|February 24, 2019
Global elimination of cervical cancer as a public health problemMarc Brisson, Mélanie Drolet
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccination - Authors' replyMélanie Drolet, Marc Brisson
Journal of the National Cancer Institute|January 9, 2013
Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccinationMarc Brisson, Mélanie Drolet, Talía Malagón
Emerging Infectious Diseases|December 23, 2015
Human Papillomavirus Vaccination at a Time of Changing Sexual BehaviorIacopo Baussano, Fulvio Lazzarato, Marc Brisson, et al.
The Lancet. Global Health|August 9, 2014
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling studyMark Jit, Marc Brisson, Allison Portnoy, et al.
Preventive Medicine|December 14, 2020
From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectivenessMark Jit, Kiesha Prem, Elodie Benard, et al.
Lancet (London, England)|July 1, 2019
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysisMélanie Drolet, Élodie Bénard, Norma Pérez, et al.
Pageof 15